Last reviewed: July 9, 2026
Last updated: July 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has become one of the most effective medications for weight loss, with clinical trials showing participants losing up to 15% of their body weight. However, the right dosage isn't one-size-fits-all—it depends on your individual health profile, tolerance, and weight loss goals. PlexusDx works with you to find your optimal dose through a structured, gradual approach.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Semaglutide Dosage Works for Weight Loss
Semaglutide is a GLP-1 receptor agonist that works by slowing stomach emptying and signaling fullness to your brain. The medication doesn't work at a fixed dose for everyone—your body's response to a 0.5 mg injection differs from someone else's response to the same dose. This is why treatment always begins with a low starting dose and increases gradually over 16 to 20 weeks. The gradual titration approach helps your digestive system adjust and reduces nausea, vomiting, and other initial side effects.
Most semaglutide weight loss programs use a standard titration schedule: starting at 0.25 mg per week, then moving to 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg as your maintenance dose. However, some patients reach their weight loss goals at lower doses, while others benefit from staying at intermediate levels. Your ideal dose is the one that produces steady weight loss while keeping side effects manageable—not necessarily the highest dose available.
What Research Shows About Effective Semaglutide Dosing
Clinical data from the STEP trials demonstrated that higher doses produce greater weight loss, but the difference between 1.7 mg and 2.4 mg weekly is modest for many patients. At 1.7 mg per week, the average weight loss was approximately 15% of starting body weight over 68 weeks, while 2.4 mg showed about 17% weight loss in similar timeframes. This means that staying at a lower, well-tolerated dose may deliver meaningful results without requiring you to push through uncomfortable side effects. The research emphasizes that consistency and adherence matter more than reaching the maximum dose.
Individual factors like your baseline weight, metabolism, existing health conditions, and how your body's peptide pathways respond to GLP-1 signaling all influence the dose that works best for you. Some people are naturally more sensitive to GLP-1 receptor activation, while others have genetic variations in appetite-regulating genes that affect how they respond. This is why personalized guidance—rather than a standard protocol—produces better long-term outcomes and higher treatment satisfaction.
Starting Your Semaglutide Dosage: What to Expect
When you begin compounded semaglutide through PlexusDx, your first injection is typically 0.25 mg administered once per week. This micro-dose allows your body to become accustomed to GLP-1 receptor activation before moving to higher concentrations. Most people notice mild appetite suppression within a few days, though hunger reduction becomes more pronounced as your dose increases. Common initial side effects—nausea, mild gastrointestinal discomfort, and reduced appetite—usually improve within the first two to three weeks as your body adapts.
Your dose increases every week or every two weeks depending on your tolerance and clinical protocol. If you experience significant nausea or other side effects, your provider can pause at the current dose for an extra week, giving your body more time to adjust before advancing. This flexible approach means you're never forced to move up in dose if you're not ready, and your price remains flat regardless of which dose level you're taking. PlexusDx's model ensures your dose may need to go up, but your price won't.
Finding Your Optimal Maintenance Dose
Your optimal maintenance dose is the amount that produces consistent weight loss without causing intolerable side effects or interfering with your daily life. For some patients, this is 0.5 mg weekly; for others, it's 1.7 mg or 2.4 mg. Most weight loss occurs in the first 16 weeks of treatment, then continues more gradually as your body reaches a new steady state. Once you reach a dose that works well, you typically stay at that level for ongoing weight management rather than continuing to increase indefinitely.
The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Semaglutide Dosage Adjustments and Long-Term Management
After you reach your maintenance dose, adjustments are typically made only if your weight loss plateaus, you experience new or worsening side effects, or your health circumstances change. Some patients benefit from a dose reduction if they develop persistent nausea even after several weeks at a higher level. Others may find that holding steady at a moderate dose provides excellent results without the digestive challenges sometimes seen at maximum doses. The goal is sustainable, long-term weight management rather than aggressive short-term loss.
Your PlexusDx provider reviews your progress monthly and adjusts your treatment plan based on your actual results and how you're feeling. If you're losing weight consistently, tolerate your current dose well, and feel energized and healthy, there's no clinical reason to increase. Conversely, if you've plateaued for six to eight weeks, a dose increase may jumpstart results. This personalized, responsive approach respects your individual physiology rather than applying a rigid, one-size-fits-all protocol.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
Most semaglutide weight loss programs begin with 0.25 mg injected once per week. This low starting dose allows your body to adjust to the medication before gradually increasing to higher therapeutic levels over 16 to 20 weeks. PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan with personalized dosing schedules.
Is 2.4 mg the best dose for weight loss results?
While 2.4 mg weekly is the highest standard maintenance dose studied in clinical trials, it is not necessarily the best dose for every patient. Clinical data shows that 1.7 mg produces significant weight loss for many people, with only modest additional benefit at 2.4 mg. Your optimal dose depends on your individual tolerance, response, and weight loss progress—not on reaching the maximum available amount.
How much does semaglutide cost at PlexusDx for different doses?
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain the same price regardless of your dose level. Whether you're taking 0.5 mg or 2.4 mg weekly, your monthly cost doesn't change as your dose increases. There is no membership fee, and treatment is available in all 50 states without requiring insurance.
What are the side effects at higher semaglutide doses?
Common side effects at higher doses include nausea, vomiting, constipation, and reduced appetite for favorite foods. Most side effects improve within the first few weeks as your body adapts. If you experience persistent or severe side effects, your provider can slow your titration, pause at your current dose longer, or even reduce to a lower maintenance level that still produces meaningful weight loss.
How does the Precision Peptide Genetic Test relate to my GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Nausea on Wegovy: What You Can Take for Relief and Support
How Effective is Wegovy for Weight Loss: A Comprehensive Overview